Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Moodys
Medtronic

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Betamethasone valerate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for betamethasone valerate and what is the scope of freedom to operate?

Betamethasone valerate is the generic ingredient in eight branded drugs marketed by Perrigo Uk Finco, Riconpharma Llc, Taro, Mylan, Acp Nimble, Roaco, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Savage Labs, Schering, Actavis Mid Atlantic, Anima, and Teva Pharms, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone valerate. Fifteen suppliers are listed for this compound.

Drug Prices for betamethasone valerate

See drug prices for betamethasone valerate

Recent Clinical Trials for betamethasone valerate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Association pour la Recherche Clinique et ImmunologiqueN/A
Galderma R&DPhase 2
GlaxoSmithKlinePhase 1

See all betamethasone valerate clinical trials

Recent Litigation for betamethasone valerate

Identify potential future generic entrants

District Court Litigation
Case NameDate
Connetics Corporation v. Pentech Pharmaceuticals Inc2008-04-18
Bone Care International LLC v. Pentech Pharmaceuticals, Inc.2008-02-21
CONNETICS CORPORATION v. AGIS INDUSTRIES (1983)LTD.

See all betamethasone valerate litigation

Pharmacology for betamethasone valerate
Medical Subject Heading (MeSH) Categories for betamethasone valerate
Synonyms for betamethasone valerate
(11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate
(11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate
(2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl p
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate
[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate
1,4-Pregnadiene-11beta,17alpha,21-triol-9alpha-fluoro-16beta-methyl-3,20-dione 17-valerate
12772-60-0
149665-14-5
152M445
2152-44-5
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate
9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate #
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate
9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate
9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate
944728-94-3
9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17-valerate
9alpha-Fluoro-16beta-methylprednisolone 17-valerate
9IFA5XM7R2
AB01274710_02
AB01274710-01
AB2000222
AC1L285F
AKOS015994704
AN-14218
Bedermin
beta-Methasone 17-valerate
beta-Val
Beta-Val (TN)
Betaderm
Betamethason-17-valerate
Betamethasone 17-valerate
Betamethasone 17a-valerate
Betamethasone 17alpha-valerate
Betamethasone Valerate (Betamethasone 17-Valerate)
Betamethasone valerate (Betnovate)
Betamethasone valerate (JP17/USP)
Betamethasone valerate [USAN:BAN:JAN]
Betamethasone valerate [USAN:USP:JAN]
Betamethasone-17-valerate
Betatrex (Salt/Mix)
Betaval
Betnesol V
Betnesol-V
Betneval
Betnovate
Betnovate;Celestone;Betaderm;Luxiq
Betnovateat
Betoid
Bettamousse
Bextasol
BRD-K34032314-001-04-1
C27H37FO6
CAS-2152-44-5
Celestan V
Celestan-V
Celestane V
Celestoderm
Celestoderm V
Celestoderm-V
Celeston valerate
CHEBI:31277
CHEMBL1497
Chlorophytum Borivilanum
D01357
Dermosol
Dermovaleas
DSSTox_CID_2673
DSSTox_GSID_22673
DSSTox_RID_76684
DTXSID7022673
Ecoval 70
EINECS 218-439-3
entanoate
Flubenisolonvalerate
Fuciderm
Gentocin (Salt/Mix)
Gentocin (Veterinary)
KS-1198
LS-118456
Luxiq
Luxiq (TN)
MFCD00867446
MolPort-003-933-651
NCGC00255185-01
NCGC00274064-01
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-,(11-beta,16-beta)-
Rinderon V
Rinderon-V (TN)
RL02645
s1690
SCHEMBL7270
SNHRLVCMMWUAJD-SUYDQAKGSA-N
ST075178
Stanoval
Tokuderm
Topagen (Salt/Mix)
Topagen (Veterinary)
Tox21_302288
UNII-9IFA5XM7R2
Valnac
ZINC3882052
Paragraph IV (Patent) Challenges for BETAMETHASONE VALERATE
Tradename Dosage Ingredient NDA Submissiondate
LUXIQ AEROSOL, FOAM;TOPICAL betamethasone valerate 020934 2007-08-10

US Patents and Regulatory Information for betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro DERMABET betamethasone valerate CREAM;TOPICAL 072041-001 Jan 6, 1988 AB RX No No   Start Trial   Start Trial   Start Trial
Schering VALISONE betamethasone valerate CREAM;TOPICAL 016322-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Schering VALISONE betamethasone valerate LOTION;TOPICAL 016932-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Taro BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 070062-001 May 14, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 070051-001 Oct 10, 1984 AB RX No No   Start Trial   Start Trial   Start Trial
Perrigo New York BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 070053-001 Jun 10, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999   Start Trial   Start Trial
Mylan LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Harvard Business School
Medtronic
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.